
The $2.65 billion merger between Patheon and DSM’s pharma business has completed, creating a new privately-held company called DPx. The …

Contract manufacturing organisation DSM Pharmaceutical Products is planning to officially open a new biopharma plant in Australia in July as …
Actavis revises supply deal with Sagent, facility updates from Marken and SAFC, a supply deal for DSM plus another J&J …
A round up of recent pharma manufacturing news, including an Ipsen/Inspiration facility up for sale, new contracts for Patheon, Cytovance …
DSM Pharmaceutical Products has teamed up with Almac to offer biocatalysis services to customers in the drug industry. By working …
DSM said its pharmaceutical business unit posted ‘weak’ financials in the first quarter of 2012, although revenues rose and there …
German chemical and pharmaceutical company Merck KGaA is planning to set up a plant to make inorganic salts used in …
Pharmafocus’ round-up of developments in the pharmaceutical manufacturing sector includes new contracts for CMOs Lonza and DSM, facility news for …
Dutch fine chemicals company DSM has said it will look for new partners in China after dissolving a joint venture …